Fulcrum Therapeutics, Inc. (FULC) Ownership

$3.63

south_east
-$0.06 (-1.63%)
Day's range
$3.56
Day's range
$3.72

Fulcrum Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 11/14/2024 10.23 M $36.52 M   -11.89% 16.39%
BLACKROCK FUNDING, INC. /DE 11/13/2024 5.71 M $20.37 M   100.00% 9.14%
TCG CROSSOVER MANAGEMENT, LLC 11/14/2024 5.25 M $18.74 M   100.00% 8.41%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2024 4.78 M $17.06 M   100.00% 7.66%
VANGUARD GROUP INC 11/13/2024 3.27 M $11.69 M   6.62% 5.25%
TRV GP IV, LLC 11/06/2024 2.34 M $8.37 M   0.00% 3.75%
CAPTION MANAGEMENT, LLC 11/14/2024 2.21 M $7.90 M   6.17% 3.55%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2024 2.00 M $7.14 M   566.67% 3.20%
FMR LLC 11/13/2024 1.72 M $6.15 M   -67.65% 2.76%
STATE STREET CORP 11/14/2024 1.68 M $6.00 M   61.36% 2.69%
PERCEPTIVE ADVISORS LLC 11/14/2024 1.50 M $5.36 M   100.00% 2.40%
LOGOS GLOBAL MANAGEMENT LP 11/14/2024 1.50 M $5.36 M   0.00% 2.40%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 1.42 M $5.08 M   -3.88% 2.28%
CITADEL ADVISORS LLC 11/14/2024 1.35 M $4.82 M   -24.10% 2.16%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.32 M $4.72 M   1.03% 2.12%
CAPTION MANAGEMENT, LLC 11/14/2024 1.20 M $4.30 M   473.48% 1.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2024 1.18 M $4.22 M   -53.45% 1.90%
BRAIDWELL LP 11/14/2024 1.07 M $3.82 M   100.00% 1.71%
GOLDMAN SACHS GROUP INC 11/14/2024 927,961 $3.31 M   65.56% 1.49%
D. E. SHAW & CO., INC. 11/14/2024 757,731 $2.71 M   28.04% 1.21%
WOODLINE PARTNERS LP 11/14/2024 670,807 $2.39 M   33.81% 1.07%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 569,185 $2.03 M   223.43% 0.91%
NORTHERN TRUST CORP 11/13/2024 567,743 $2.03 M   240.18% 0.91%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 556,900 $1.99 M   324.14% 0.89%
IKARIAN CAPITAL, LLC 11/14/2024 422,800 $1.51 M   100.00% 0.68%
TWO SIGMA ADVISERS, LP 11/14/2024 382,200 $1.36 M   -32.17% 0.61%
SIMPLIFY ASSET MANAGEMENT INC. 11/12/2024 351,314 $1.25 M   -47.94% 0.56%
MORGAN STANLEY 11/14/2024 350,685 $1.25 M   -71.60% 0.56%
ASSENAGON ASSET MANAGEMENT S.A. 10/23/2024 340,495 $1.22 M   -31.55% 0.55%
CAPTION MANAGEMENT, LLC 11/14/2024 307,414 $1.10 M   -41.48% 0.49%
SHAY CAPITAL LLC 11/14/2024 289,237 $1.03 M   100.00% 0.46%
BESSEMER GROUP INC 11/12/2024 286,988 $1.03 M   0.00% 0.46%
TWO SIGMA INVESTMENTS, LP 11/14/2024 272,107 $971,422   -46.61% 0.44%
SHERBROOKE PARK ADVISERS LLC 11/14/2024 227,225 $811,193   100.00% 0.36%
MASS GENERAL BRIGHAM, INC 10/16/2024 205,356 $733,121   0.00% 0.33%
CITADEL ADVISORS LLC 11/14/2024 202,200 $721,854   705.58% 0.32%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/14/2024 202,030 $721,247   100.00% 0.32%
CITADEL ADVISORS LLC 11/14/2024 195,000 $696,150   68.54% 0.31%
ACADIAN ASSET MANAGEMENT LLC 11/12/2024 188,961 $674,000   100.00% 0.30%
JPMORGAN CHASE & CO 12/26/2024 187,163 $668,173   466.46% 0.30%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2024 176,161 $628,895   -3.59% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 171,200 $611,184   100.00% 0.27%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 169,549 $605,290   0.00% 0.27%
HAP TRADING, LLC 11/12/2024 163,200 $59,843   100.00% 0.26%
HAP TRADING, LLC 11/12/2024 147,300 $2,336   194.60% 0.24%
BANK OF NEW YORK MELLON CORP 11/12/2024 138,747 $495,327   -25.70% 0.22%
FIDUCIARY TRUST CO 11/14/2024 136,555 $487,501   0.00% 0.22%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/08/2024 132,784 $474,039   100.00% 0.21%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2024 129,100 $460,887   100.00% 0.21%
BARCLAYS PLC 11/19/2024 124,141 $443,000   367.12% 0.20%

Fulcrum Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 163 institutional investors and hedge funds held shares of Fulcrum Therapeutics, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 5.17 M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC: 526,045

Bank of New York Mellon Corp: 141,873

Matisse Capital: 128,445

RHUMBLINE ADVISERS: 88,607

DekaBank Deutsche Girozentrale: 60,000

87.76% of Fulcrum Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 58.53 M shares in the last 24 months. This purchase volume represents approximately $212.47 M in transactions.